Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US

by Raja Nandhini on  March 7, 2013 at 9:20 AM Drug News
RSS Email Print This Page Comment
Font : A-A+

Hyderabad based drug firm Dr Reddy's Laboratories has recently announced its launch of generic Zoledronic Acid injections in the US market.

The injection in 4 mg/5 ml strength is approved by the US Food and Drug Administration (USFDA) and is available in single use vials.
Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US
Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US

The drug, which is a bioequivalent generic version of Novartis AG's (NVS) Zometa, is used along with anti-cancer drugs to prevent bone fractures in patients with multiple myeloma and prostate cancer and for treating osteoporosis.

This has hiked the values of the firm's share by nearly 1.06%.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive